11.3 Automated Methods, MALDI-TOF MS, Molecular, and 16S Sequencing

11.3 Automated Methods, MALDI-TOF MS, Molecular, and 16S Sequencing

Quick Answer: Automated phenotypic systems and MALDI-TOF MS identify most routine colonies in minutes to hours, but MALDI cannot reliably separate Shigella from E. coli or S. pneumoniae from the S. mitis group. Use inactivated-spot technique for biosafety. Reflex to biochemicals, antigen tests, PCR, or 16S sequencing when the score is low, the morphology is discordant, or species-level resolution is required.

Once a colony is isolated, laboratories identify it with a stack of technologies. The M(ASCP) candidate must know what each method actually measures, where it fails, and when to stop and choose a different method. "The instrument said so" is not an identification. Outline II.J groups automated phenotypic systems, MALDI-TOF mass spectrometry, molecular assays, and 16S sequencing as identification methods whose theory, interpretation, and application you must be able to defend.

Automated phenotypic systems

Vitek 2, BD Phoenix, and MicroScan WalkAway incubate miniaturized biochemical (and often susceptibility) panels, read colorimetric or turbidimetric changes kinetically, and match those patterns to a taxonomic database. They are faster than overnight API strips and more standardized than a bench rack of TSI tubes, but they remain phenotypic: they infer identity from metabolic activity, not from a protein fingerprint or a gene sequence.

Application points that decide whether the printed name is reportable:

• Purity and McFarland inoculum still matter. A mixed colony produces chimeric biopatterns that may match a species that is not on the plate.
• Fastidious organisms may fail to metabolize enough substrate to generate a profile and come out as unidentified.
• Anaerobes, mycobacteria, and nocardioform organisms often need dedicated cards or a different platform entirely.
• As with manual kits, select-agent suspects do not go on open automated systems.

Automated systems shine for common Enterobacterales, staphylococci, enterococci, and many non-fermenters when the colony matches the identification. They fail when the organism is inert, slow, or absent from the database. Low-probability or "unidentified" calls are a prompt to MALDI-TOF, conventional tests, or molecular methods — not a prompt to pick the first name on a differential list and report it. If Gram stain says Gram-positive rods and the card says Neisseria, the culture is mixed or the inoculum is wrong; the card is not more true than the smear.

MALDI-TOF MS: ionization of proteins and spectral libraries

Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry ionizes abundant bacterial proteins (largely ribosomal proteins) from a colony smeared with matrix, commonly α-cyano-4-hydroxycinnamic acid. Laser energy desorbs and ionizes those proteins; the time of flight to the detector is a function of mass-to-charge ratio and creates a spectrum. Software compares that spectrum with a validated library (Bruker Biotyper, VITEK MS, and similar). A high confidence score or confidence category supports a genus or species report per laboratory SOP; a low score is unidentified, not a license to report the top match.

Direct colony spotting is used for many routine isolates. Formic-acid on-plate extraction or ethanol-formic acid tube extraction improves spectra for yeasts, some Gram-positives, and mucoid colonies, and it is also the biosafety-relevant inactivation path.

Strengths the exam expects you to recite:

• Identification in minutes after a colony exists, far faster than overnight biochemicals.
• Broad coverage of bacteria, yeasts, and many anaerobes as libraries expand.
• Low consumable cost per isolate once the instrument is in place.
• Independence from many carbohydrate reactions that fail in inert or asaccharolytic organisms.

Limitations you must not miss:

• Shigella versus E. coli. These taxa are extremely closely related; MALDI-TOF cannot reliably distinguish them. A stool or dysentery-associated isolate called E. coli by MALDI still needs biochemical screening (TSI K/A, nonmotile, typical decarboxylase pattern), Shiga toxin testing as indicated, and serologic or molecular confirmation before Shigella is excluded or reported. Reporting MALDI E. coli from a bloody stool without that reflex is a public-health miss.
• S. pneumoniae versus the S. mitis group. Spectra overlap. A respiratory, ear, or blood isolate identified as S. pneumoniae/S. mitis group requires optochin, bile solubility, or a pneumococcal-specific antigen or molecular assay before you report pneumococcus — especially from sterile sites, where the clinical difference is large and viridans streptococci are common contaminants or pathogens of a different syndrome.
• Other library-dependent pairs (depending on extraction method and database version) can include some Burkholderia, viridans streptococci at species level, coagulase-negative staphylococci at species level, and some Neisseria. Treat a low score as unidentified.
• MALDI does not replace serotyping, toxin detection, or antimicrobial susceptibility testing. It names the protein fingerprint, not the capsule, not Shiga toxin, and not mecA.

Inactivated-spot biosafety: Direct open-bench spotting of a possible BSL-3 organism is an exposure. Use inactivation (ethanol-formic acid tube extraction or a manufacturer-validated inactivated-spot method) inside a biosafety cabinet for isolates with select-agent colony morphology, slowly growing Gram-negative coccobacilli from blood, or other high-risk presentations. Even routine spotting should follow the laboratory's aerosol and waste rules. MALDI is an identification method, not a reason to skip the LRN algorithm. If the colony looks like anthrax, plague, brucellosis, tularemia, or melioidosis, you do not "just MALDI it" on the open instrument.

Molecular methods: PCR, multiplex panels, and probes

Nucleic acid tests detect organism-specific DNA or RNA rather than metabolic products or protein spectra.

• Targeted PCR (for example tcdB for C. difficile, mecA, antepartum group B streptococcus screening, Bordetella, N. gonorrhoeae/C. trachomatis NAAT) is highly sensitive but only answers the question it was designed to ask.
• Multiplex syndromic panels (CSF meningitis/encephalitis, respiratory, stool, joint fluid) identify a fixed menu of pathogens, often directly from the specimen and sometimes without a colony. They do not produce an isolate for AST unless culture is performed in parallel, and they do not detect off-menu organisms.
• Probe methods (historically AccuProbe and PNA-FISH) hybridize to rRNA or other targets in smears or broths and can identify selected organisms from positive blood-culture bottles faster than subculture.

Interpretation traps: a positive PCR from a non-sterile site may detect colonization rather than infection; a negative multiplex panel does not exclude an organism that is not on the menu; internal inhibition controls must pass or the negative result is invalid. Molecular identification of a colony (for example S. aureus plus mecA PCR) is complementary to MALDI, not a license to skip purity checks. If two colony types are present, the PCR may amplify the wrong one.

16S rRNA gene sequencing

When phenotypic methods and MALDI-TOF do not identify an isolate, 16S rRNA gene sequencing compares amplified ribosomal sequence to public or curated databases. The 16S gene is about 1,500 base pairs with conserved priming sites and variable regions that provide taxonomic signal. It is the classic tool for unusual Gram-positive rods, fastidious Gram-negatives, and organisms that will not grow well in kit wells.

Limitations that are tested as interpretation items:

• Species resolution is incomplete. 16S may not separate E. coli from Shigella, members of the Bacillus cereus group (including B. anthracis), some Enterobacter cloacae complex members, or S. pneumoniae from S. mitis. A genus-level 16S result is an honest report when percent identity is shared among several species. Do not over-call a species because the first BLAST hit looks familiar.
• Mixed cultures yield mixed electropherograms that cannot be interpreted. Sequence a pure isolate; if the plate is mixed, subculture first. 16S is not a deconvolution tool for two organisms in one tube.
• Database quality and percent-identity cutoffs (CLSI MM18 is the usual interpretive framework) determine whether you report species, genus, or "closest related taxon."
• 16S does not provide susceptibility, serotype, or toxin information. A 16S name of Escherichia does not tell you whether the isolate is a Shiga toxin producer.

When to reflex from MALDI to biochemicals or molecular methods

Reflex when any of the following is true:

1. The MALDI score is below the laboratory's species cutoff, or the top matches disagree with each other.
2. Colony morphology, Gram stain, oxidase, catalase, or hemolysis disagrees with the MALDI name.
3. The identification is a known MALDI-blind pair (Shigella/E. coli, S. pneumoniae/mitis group) and the specimen type makes the distinction clinically or epidemiologically important.
4. Public-health or sterile-site reporting requires a serotype, a toxin, or a species that MALDI cannot claim.
5. The isolate is a possible select agent — MALDI on an open instrument is not the next step; LRN referral is.

In those cases, go back to conventional biochemicals (TSI, motility, decarboxylases, optochin, bile solubility, serology) or forward to PCR or 16S. Automated phenotypic cards can also serve as a reflex when MALDI libraries lack the taxon but the organism is a typical fermenter that the card database covers. The competent identification algorithm is not a single instrument; it is a sequence of methods whose failures you can name. That is the application half of outline II.J.

Use the stack in that order for most routine colonies: confirm the Gram stain, apply rapid tests when they add a 30-second branch, identify with MALDI or an automated card, and reflex with biochemicals or sequencing only when the name and the colony do not tell the same story.